WATSON LABS INC FDA Approval ANDA 064204

ANDA 064204

WATSON LABS INC

FDA Drug Application

Application #064204

Documents

Review1998-02-16

Application Sponsors

ANDA 064204WATSON LABS INC

Marketing Status

Discontinued001

Application Products

001FOR SUSPENSION;ORALEQ 125MG BASE/5ML0CEFACLORCEFACLOR

FDA Submissions

ORIG1AP1998-02-18
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1999-03-05
LABELING; LabelingSUPPL4AP1999-05-03
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2000-12-08

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL5Null0

CDER Filings

WATSON LABS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 64204
            [companyName] => WATSON LABS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CEFACLOR","activeIngredients":"CEFACLOR","strength":"EQ 125MG BASE\/5ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CEFACLOR","submission":"CEFACLOR","actionType":"EQ 125MG BASE\/5ML","submissionClassification":"FOR SUSPENSION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.